Premium
Arcus Biosciences Inc (RCUS)
NYSE
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule... Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB680, and Zimberelimab. Arcus conducts clinical trials for different types of cancers such as Prostate, Lung, Colorectal, Pancreatic, and others. The company operates through the single segment being the business of developing and commercializing immunotherapies. Show more
Dr. Markus will oversee Arcus’s clinical development organization and portfolio that includes seven clinical-stage programs with multiple ongoing Phase 3 studies Arcus Biosciences, Inc...
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today...
Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, announced that...
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.8 | -5.61403508772 | 14.25 | 14.4499 | 13.33 | 690218 | 13.86181482 | CS |
| 4 | -2.41 | -15.1954602774 | 15.86 | 16.08 | 13.33 | 564673 | 14.49107278 | CS |
| 12 | -2.54 | -15.8849280801 | 15.99 | 18.98 | 13.33 | 697443 | 15.68778012 | CS |
| 26 | -0.92 | -6.40222686152 | 14.37 | 18.98 | 13.33 | 668223 | 16.16419707 | CS |
| 52 | -1.96 | -12.7190136275 | 15.41 | 20.31 | 13.33 | 712909 | 16.39795311 | CS |
| 156 | -16.91 | -55.69828722 | 30.36 | 39.75 | 12.95 | 866573 | 21.12972836 | CS |
| 260 | 3.62 | 36.8260427263 | 9.83 | 49.1 | 8.55 | 756280 | 23.70619238 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
